Recent advances in microfluidic-based cancer immunotherapy-on-a-chip strategies
- 1 January 2023
- journal article
- review article
- Published by AIP Publishing in Biomicrofluidics
- Vol. 17 (1) , 011501
Abstract
Despite several extraordinary improvements in cancer immunotherapy, its therapeutic effectiveness against many distinct cancer types remains mostly limited and requires further study. Different microfluidic-based cancer immunotherapy-on-a-chip (ITOC) systems have been developed to help researchers replicate the tumor microenvironment and immune system. Numerous microfluidic platforms can potentially be used to perform various on-chip activities related to early clinical cancer immunotherapy processes, such as improving immune checkpoint blockade therapy, studying immune cell dynamics, evaluating cytotoxicity, and creating vaccines or organoid models from patient samples. In this review, we summarize the most recent advancements in the development of various microfluidic-based ITOC devices for cancer treatment niches and present future perspectives on microfluidic devices for immunotherapy research.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST 110-2636-B-006-013-)
- Ministry of Science and Technology, Taiwan (MOST 110-2740-B-006-002)
- Ministry of Science and Technology, Taiwan (MOST 111-2636-B-006-010)
- Ministry of Science and Technology, Taiwan (MOST 111-2740-B-006-002)
This publication has 116 references indexed in Scilit:
- Abstract B98: Serial evaluation of PD-L1 expression on circulating tumor cells (CTCs)Molecular Cancer Therapeutics, 2015
- Using microfluidics to investigate tumor cell extravasation and T-cell immunotherapies2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), 2015
- Abstract 1582: Isolation of circulating tumor cells and evaluation of PD-L1 expression in metastatic lung cancerCancer Research, 2015
- Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroidsBMC Cancer, 2015
- Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitroProceedings of the National Academy of Sciences, 2013
- Patient-derived tumour xenografts as models for oncology drug developmentNature Reviews Clinical Oncology, 2012
- Reconstituting Organ-Level Lung Functions on a ChipScience, 2010
- The origins and the future of microfluidicsNature, 2006
- Microstructure Technologies and their Potential in Medical Applicationsmin - Minimally Invasive Neurosurgery, 1994
- Production and Characterization of Improved Liposomes Containing Radiographic Contrast MediaInvestigative Radiology, 1990